Stay updated on AB680 Safety in Gastrointestinal Malignancies Clinical Trial
Sign up to get notified when there's something new on the AB680 Safety in Gastrointestinal Malignancies Clinical Trial page.

Latest updates to the AB680 Safety in Gastrointestinal Malignancies Clinical Trial page
- Check4 days agoNo Change Detected
- Check12 days agoChange DetectedRemoved a site (Mid-Florida Hematology & Oncology Centers, PA) and its Orange City, FL address. The total number of locations is now listed as 17 (revision: v3.4.2).SummaryDifference0.3%

- Check19 days agoChange DetectedMinor version update from Revision: v3.4.0 to v3.4.1 with no visible changes to study content or page behavior. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check34 days agoChange DetectedThe label changes from 'Last Update Posted (Estimated)' to 'Last Update Posted'. This is a small metadata update that clarifies when the page was last updated without changing substantive trial information.SummaryDifference0.0%

- Check41 days agoChange DetectedRevision note updated to v3.3.4 and v3.3.3 removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check48 days agoChange DetectedTwo new sites were added to the study locations: Medical Oncology Associates in Spokane, WA, and Mid-Florida Hematology & Oncology Centers in Orange City, FL. The total number of locations increased to 18 (from 16).SummaryDifference0.4%

- Check63 days agoChange DetectedLocations are now presented under a single Locations section with state-specific sites; the HHS Vulnerability Disclosure link was removed and the revision updated to v3.3.3.SummaryDifference0.9%

Stay in the know with updates to AB680 Safety in Gastrointestinal Malignancies Clinical Trial
Enter your email address, and we'll notify you when there's something new on the AB680 Safety in Gastrointestinal Malignancies Clinical Trial page.